Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
about
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapyAnti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactamsProphylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapyAntibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapyGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveClinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting.Characterization of bacterial infections in allogeneic hematopoietic stem cell transplant recipients who received prophylactic levofloxacin with either penicillin or doxycycline.2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.Targeting the transposase domain of the DNA repair component Metnase to enhance chemotherapyAntibiotic prophylaxis in patients receiving hematopoietic stem cell transplant.Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia.A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findingsAntibacterial prophylaxis in neutropenic children with cancerEvidence-based guidelines for empirical therapy of neutropenic fever in Korea.Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.New agents for the prevention of opportunistic infections in haematopoietic stem cell transplant recipients.Antibiotic prophylaxis for patients with acute leukemia.Prophylaxis with levofloxacin: impact on bacterial susceptibility and epidemiology in a hematopoietic stem cell transplant unitAutologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient program.Infection prevention in the cancer center.The role of prophylactic antimicrobials during autologous stem cell transplantation: a single-center experience.Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation.Early infections in adult patients undergoing unrelated donor cord blood transplantation.Infectious complications in breast cancer patients undergoing peripheral blood stem cell transplantation: a single center retrospective analysis towards outpatient strategy.Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance.Infections and association with different intensity of chemotherapy in children with acute myeloid leukemiaPharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies.Prophylactic meropenem during neutropenia in allogeneic stem cell transplant recipients.Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic stem cell transplantation.Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today?Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation.A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
P2860
Q24203869-5E18E607-ED6B-4839-916B-E3E196BA4824Q24236653-7A05A9F3-F1FB-47B6-87BE-02DDDBABAA27Q24241680-7178A863-D653-457F-8A35-24F79E6B58F3Q24245774-2B850E9A-2245-4130-8A7E-D673D07F0673Q28388806-9D3317D5-6114-422A-A69C-657EB2B6FEB2Q33390898-B5FE90DF-AF69-4AC3-976B-EC1C309C8055Q34030902-DDA0AFEA-046C-4217-A193-845B698F5047Q34114674-F1C76A20-2EA5-4A81-8121-EFEDE483A560Q34454737-666BA5C6-7DB1-4F39-8AC2-9FF8324CBCA2Q34580312-6510F7CF-446C-4161-A335-D629B539F214Q34583481-52D45290-B4F2-4CA2-825B-3E2FCC9039EBQ34627796-4B184E1A-E0A1-4801-91AA-E8676DF852B8Q35010336-5AB283B0-E00F-44EC-873C-C75A82A8E624Q35033597-93EC2DAF-F3C4-4353-96D9-2A27E61595A0Q35937307-7B03F809-1E63-4F95-9DAF-67CE986131E2Q36222041-100E21AD-6C41-489D-AB08-B84DB8117BF0Q37071680-B4314280-0A97-40A6-9C20-999F83B54A6FQ37628616-B66848A5-7664-46AE-B07F-D88B97FB01CBQ38025703-530399E6-B44F-496A-AF88-D2990171C2A2Q38104929-4AFD0502-1D10-4B59-AA3A-6B9A41FD4261Q40303842-FE599DEC-713C-4896-A88B-A24F910DADECQ40545174-6EB3896B-9E0D-4A3E-9210-00B61CD02A4FQ40569370-27DA9CFC-1B1C-4152-9CE3-ACA419250425Q40590665-6E573ED1-DB55-4B21-9BF2-9106D7C36BD7Q40592915-C99BFC4A-7DBD-41BB-9222-0B05978EA85DQ41764159-2274483D-39BF-4F8C-8FD4-413CB04E532CQ44750600-DFDD9017-D9DB-4F11-A3E3-17159B7CABEDQ44789000-1471C442-96F3-4E04-9141-E4F58C37F3E2Q45235073-504DDFC4-0CA3-49F0-B457-B3464EBA5B13Q47709323-012C2449-4021-4811-A384-044F7363B79CQ48109300-6D0B45C8-FD14-4F37-B105-96774DEE10DCQ50080905-CEE5D018-13B4-43E7-BD07-FB5A1436E259
P2860
Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
@ast
Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
@en
Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
@nl
type
label
Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
@ast
Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
@en
Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
@nl
prefLabel
Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
@ast
Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
@en
Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
@nl
P2093
P921
P1476
Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
@en
P2093
P304
P356
10.1200/JCO.1998.16.3.1179
P407
P577
1998-03-01T00:00:00Z